期刊文献+

黄连素联合二甲双胍治疗胰岛素抵抗多囊卵巢综合征的临床研究 被引量:7

Therapeutic Effect of Berberine Combined with Diformin for Women with Polycystic Ovary Syndrome and Insulin Resistance
下载PDF
导出
摘要 [目的]探讨使用黄连素联合二甲双胍治疗胰岛素抵抗多囊卵巢综合征患者对BMI、LH、LH/FSH、T、HOMA(IR)及排卵率的影响。[方法]将58例患者随机分为对照组和治疗组两组,对照组给予二甲双胍,1500mg,分3次服用,口服3个月;治疗组在对照组基础上加用黄连素0.5g,3次/d,连用3个月。观察治疗前后体重指数、性激素水平、胰岛素抵抗及排卵率的变化。[结果]与治疗前比较,两组BMI、LH、LH/FSH、T、HOMA(IR)均明显下降,排卵率明显升高,差别均有统计学意义(P<0.05);治疗后与对照组比较,治疗组排卵率升高及其余指标降低明显,差异有统计学意义(P<0.05)。[结论]黄连素联合二甲双胍可以有效降低胰岛素抵抗多囊卵巢综合征肥胖患者的体重指数、性激素水平及胰岛素抵抗,提高排卵率。 [Objective]To investigate of therapeutic effect of berberine combined with diformin for women with polycystic ovary syndrome and insulin resistance.[Methods]Fifty-six women with polycystic ovary syndrome and insulin resistance were divided into two groups by random and treated with diformin(group A) or berberine combined with diformin(group B) respectively for three months,to observe the change of body mass index,sex hormone,insulin resistance and the rate of ovulating after treatment.[Results]After three months treatment,the BMI,LH,LH/FSH,T and HOMA(IR)were decreased greatly and significant difference was found between two groups.In two groups,the ovulate rate was increased greatly and significant difference was found after three months treatment.[Conclusion]Berberine combined with diformin can improve the condition of BMI and IR more effectively,increasing the rate of ovulating condition.
出处 《浙江中医药大学学报》 CAS 2011年第5期713-715,共3页 Journal of Zhejiang Chinese Medical University
关键词 多囊卵巢综合征 胰岛素抵抗 黄连素 二甲双胍 polycystic ovarian syndrome insulin resistance Berberine Diformin
  • 相关文献

参考文献3

二级参考文献15

  • 1李鄂丽.黄连素临床新用途[J].时珍国医国药,2006,17(6):1085-1085. 被引量:10
  • 2刘英敏.二甲双胍的临床合理应用与再评价[J].实用糖尿病杂志,1998,2:21-21.
  • 3[1]De Leo V.Lanxelta D,D'Antona D.et al.Hormonal effects of flutamide in young women with poycycstic ovary syndrome.J Clin EndocrinoI Metab,1998,83(1):99-102
  • 4[2]Mathews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistance and bem-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologla,1985.28:412-419
  • 5[3]Day C.Thiazolidinediones:a new class of antidiabetie drugs.Dia betic Medicine.1999.16(3):179-192
  • 6[4]Wu Z,Xie Y,Bucher NLR,et al.PPAR(gamma)induces the in sulin-dependent glucose transporter,GLUT4,in the absence of C/EBP(alpha)during the conversion of 3T3 fibroblnsts into adipocyles.J Clin Invest,1998,101:22-32
  • 7[5]Young PW,Cawthome MA,Coyle PJ,et al.Repeat nleatment of obese mice with BRL 49653.a new potent insulin sensitize en hances insulin action in white adipocytes:aasociation with in creased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.Diabetes44,1995:1087-1092
  • 8[6]Stodien LH,Baur LA,Krikelos AD,et al.Dietary fat and insulin action.Diabetologia,1996,39:621-631
  • 9[7]Okuno A.Troglitazone increases the number of small adipocytes without the charge of white adipose tissue mass in obeses Zucher rats.J Clin Invest,1998,101:1354-1361
  • 10[8]Smith V,Gogg S,Johansson A,et al.Thiazodinediones (PPAR gam ma agonists)but not PPAR alpha agonists increase IRS-2 gene expression in 373-L1 and human adipoeytes.FABSEB,2001,15(1):215-220

共引文献75

同被引文献84

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部